Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2A6 | P11509 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2865123 | 0.79 | CD44 (0.38) | — | |
| SCHEMBL1191551 | 0.79 | GRM4 (0.41) | — | |
| SCHEMBL10212397 | 0.78 | — | — | |
| SCHEMBL10209572 | 0.76 | ALDH1A1 (0.30) | CYP2A6 | |
| SCHEMBL28869513 | 0.76 | ALDH1A1 (0.43) | — | |
| SCHEMBL28184037 | 0.76 | ALDH1A1 (0.40) | CYP2A6 | |
| SCHEMBL7692434 | 0.76 | PARP1 (0.40) | CYP2A6 | |
| SCHEMBL2624867 | 0.76 | G6PD (0.42) | — | |
| SCHEMBL28225368 | 0.76 | CD44 (0.45) | CYP2A6 | |
| SCHEMBL28121126 | 0.76 | ERN1 (0.34) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8822043-B2 | Organic compound and organic light-emitting device | CANON KABUSHIKI KAISHA (JP) | 2014-09-02 | — | — | US | disclosed |
| US-20120091450-A1 | NOVEL ORGANIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE | CANON KABUSHIKI KAISHA (JP) | 2012-04-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120091450-A1 | NOVEL ORGANIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE | TRPA1, AFF4, TYR | CYP2A6 439/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.